UMIN ID: C000000256
Registered date:30/09/2005
Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Renal cell carcinoma |
| Date of first enrollment | 2001/08/01 |
| Target sample size | 540 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Administration of natural type interferon alpha for at least one year Observation |
Outcome(s)
| Primary Outcome | Local recurrence and distant metastasis |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Active synchronous malignancy Bellini duct carcinoma von Hippel-Lindau disease History of allergy for interferon or vaccine |
Related Information
| Primary Sponsor | TRAIn-Alpha study group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Kidney Foundation, Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hideyuki Akaza MD |
| Address | Japan |
| Telephone | 029-853-3223 |
| Affiliation | University of Tsukuba Department of Urology |
| scientific contact | |
| Name | Seiji Nito MD |
| Address | Fukuoka Japan |
| Telephone | |
| Affiliation | Kyushu University Department of Urology |